endoscopic retrograde
cholangiopancreatography
(ERCP) 3:23, 38
endoscopy 2:86, 197, 378; 3:7, 38,
38–40, 38 t–39t,42, 292
endotracheal intubation 4:258, 262
endotracheal tube 2:214, 217
end-stage renal disease (ESRD)
1:344; 3:187; 4: 273
aging and urinary system
changes 3: 175
Alport’s syndrome 3:176, 177
Fanconi’s syndrome 3: 190
glomerulosclerosis 3: 192
Goodpasture’s syndrome 3: 193
hemolytic uremic syndrome
3: 195
kidney donor 3: 200
kidney transplantation 3: 202
Medicare coverage for
permanent renal failure 3: 205
nephritis 3: 207
nephropathy 3: 210
polycystic kidney disease 3: 214
renal dialysis 3: 218
renal failure 3:218, 219
uremia 3: 221
urinary system 3:171, 172, 174
endurance 4:220
aerobic capacity 4: 213
blood doping 4: 324
carbohydrate loading 4: 217
sports drinks and foods 4: 231
strength 4: 232
training 4: 233
enema 3:40
enhanced external counterpulsation
(EECP) 2:54–55
enkephalin 1:362, 371
Entamoebasp. 2:306, 307; 3: 25
enteral nutrition 4:182–183, 198 ,
202
entropion 1:87
enucleation 1:88,109–110,114;
4: 380
enuresis 3:187–188
environmental carcinogens 2:370,
382
environmental cigarette smoke
2:105, 188, 201, 212; 4:22–23,
34 , 282
environmental hazard exposure
3:71, 237; 4:22, 22 t
aging and pulmonary changes
2: 183
asbestosis 2: 185
berylliosis 2: 193
bronchitis 2: 196
carcinogen 2: 374
environmental cigarette smoke
4:22–23
heavy-metal poisoning 4:30–31
methemoglobinemia 2: 157
myelodysplasia syndrome 2: 160
radiation and biochemical
injuries 4: 386
radon exposure 4: 44
eosinophil 2:120, 138, 162, 256,
276, 279
EPA. SeeUS Environmental
Protection Agency
ephedra 4:231, 348
epicondylitis 1:320–321
epidemics 2:303, 304; 4:2, 18
epidermis 1:127, 135, 154,
156–157, 170 , 180, 195
epidermolysis bullosa 1:154–155
epididymis 3:340, 342, 343
epididymitis 2:330, 358; 3:277, 308
epidural 3:260, 262; 4: 261
epiglottis 1:5, 21–22; 2:193, 195
epiglottitis 1:21–22
epilepsy 1:218, 281
epinephrine 1:161, 206, 272; 2:77,
79, 244, 245, 270; 3: 125 t
adrenal glands 3:107, 108
aldosterone 3: 112
anesthesia 4: 261
anger and anger management
4: 240
antianxiety medications 3: 359
antivenin 4: 152
dopamine 3: 124
ECT 3: 375
endocrine system 3: 99
metabolism 4: 225
nicotine 4: 345
norepinephrine 3: 152
pheochromocytoma 3: 154
tobacco 4: 353
epiphysis 1:308, 341
episcleritis 1:88
episiotomy 3: 88 , 277–278, 338
epispadias 3:188
epistaxis 1:22; 4: 362
epithelial cells 2:54, 233, 284, 290,
374–375
epithelium 1:229; 2:265, 299–302
EPO. Seeerythropoiesis;
erythropoietin
Epstein-Barr virus 2:221, 303,
323–324, 324 t,344, 345erectile dysfunction 3:278–280
amphetamines 4: 321
andropause 3: 245
antidepressant medications
3: 362
colostomy 3: 32
depression 3: 371
erection 3: 278
ginkgo biloba 4: 71
medicinal herbs and botanicals
4: 84
nicotine 4: 346
orgasm 3: 309
Peyronie’s disease 3: 319
priapism 3: 327
reproductive system 3: 238
yohimbe 4: 106
erection 3:278, 293 , 327 , 338
ergonomics 4:23–24, 23 t
erysipelas 1:155–156
erythema multiforme 1:156
erythema nodosum 1:156, 156 t
erythrasma 1:156–157
erythrocyte 2:137
aging and changes in
blood/lymph 2:123, 124
anemia 2:124, 125
antigen 2: 246
babesiosis 2: 311
bilirubin 3: 19
blood and lymph 2: 119
blood disorders 2: 121
blood doping 4: 324
bloodless surgery 4: 263
blood vessels 2: 5
capillary beds 2: 27
chromosome 4: 119
DNA 4: 122
E. coliinfection 2: 324
G6PD deficiency 4: 131
hematopoiesis 2: 140
hematuria 3: 194
hemoglobin 2: 142
hemolysis 2: 143
jaundice 3: 67
kidneys 3:201, 202
leukocyte 2: 148
malaria 2: 342
monocyte 2: 157
myelofibrosis 2: 160
oxygen-carbon dioxide
exchange 2: 216
polycythemia vera 2: 164
renal failure 3: 219
reticulocyte 2: 165
sickle cell disease 2: 165468 Index